集智股份(300553.SZ):擬委託之江實驗室就智能光纖傳感等項目進行合作開發
格隆匯5月28日丨集智股份(300553.SZ)公佈,公司於2020年5月28日召開的三屆董事會十三次會議審議通過了《關於與之江實驗室簽訂<委託開發合作協議書>的議案》,為充分發揮雙方優勢,探索科研“多元化投入”和“科技成果轉化”的機制創新,實現雙方共同發展,同意公司與之江實驗室簽訂《委託開發合作協議書》。同日,公司與之江實驗室簽署了委託開發合作開發協議,根據協議公司將委託之江實驗室就智能光纖傳感等項目進行合作開發。雙方同意以公司全資子公司杭州諦聽智能科技有限公司作為雙方合作研發的實施主體。
此次委託開發合作協議的簽訂有助於公司藉助外部研發機構的人才、技術和資源拓展公司的業務領域,推進研發項目產業化進程,符合公司戰略發展的需要。通過與外部研發機構的產學研合作,有利於提升公司在智能製造應用領域的技術創新能力及市場知名度,提高公司的核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.